SB 945: Breast and Cervical Cancer Treatment Program.
- Session Year: 2017-2018
- House: Senate
- Latest Version Date: 2018-01-29
Existing law requires the State Department of Health Care Services to perform various health functions, including providing breast and cervical cancer screening and treatment for low-income individuals. Existing law defines period of coverage as beginning when an individual is made eligible for a covered condition and not to exceed 18 or 24 months, respectively, for a diagnosis of breast cancer or a diagnosis of cervical cancer.
This bill would delete that definition and, instead, provide that the treatment services be provided for the duration of the period of treatment for an individual made eligible for treatment due to a diagnosis of breast cancer or cervical cancer, as long as the individual continues to meet all other eligibility requirements. The bill would make conforming changes to a provision relating to an individual who is diagnosed with a reoccurrence of breast cancer or cervical cancer. The bill would also make technical, nonsubstantive changes to related provisions.
For the purposes of this article, the following definitions shall apply:
(a) Covered conditions means breast or cervical cancer.
(b) Breast cancer includes primary, recurrent, and metastatic cancers of the breast, including, but not limited to, infiltrating or in situ.
(c) Cervical cancer includes all primary, recurrent, and metastatic cancers of the cervix, including, but not limited to, infiltrating or in situ, as well as cervical dysplasia.
(d) Period of coverage means the period of time beginning when an individual is made eligible under this article for a covered condition and shall not exceed the period of time the individuals eligibility for treatment services for a covered condition concludes, as described in Section 104161.1.(e)(d) Treatment services means those health care services, goods, supplies, or merchandise medically necessary to treat the covered condition or conditions with which the individual made eligible under this article has been diagnosed.
(f)(e) Uninsured means not covered for breast or cervical cancer treatment services by any of the following:
(1) No cost full scope No-cost full-scope Medi-Cal.
(2) Medicare.
(3) A health care service plan contract or policy of disability insurance.
(4) Any other form of health care coverage.
(g)(f) Underinsured means either of the following:
(1) Covered for breast or cervical cancer treatment services by any health care insurance listed in paragraph (2), (3), or (4) of subdivision (f), (e), but the sum of the individuals insurance deductible, premiums, and expected copayments in the initial 12-month period that breast or cervical cancer treatment services are needed exceeds seven hundred fifty dollars ($750).
(2) Covered by share-of-cost or limited scope limited-scope Medi-Cal, if the individual is not otherwise eligible for treatment services under the Medi-Cal program pursuant to Section 14007.71 of the Welfare and Institutions Code.
SEC. 2.Section 104161.1 of the Health and Safety Code is amended to read:104161.1.(a)When If an individual is made eligible for treatment services under this article due to a diagnosis of breast cancer, the period of coverage shall not exceed 18 months of treatment. After 18 months, the individuals eligibility for treatment services for the cancer condition that made this individual eligible concludes. treatment services shall be provided for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
(b)When If an individual is made eligible for treatment services under this article due to a diagnosis of cervical cancer, the period of coverage shall not exceed 24 months of treatment. After 24 months, the individuals eligibility for treatment services for the cancer condition that made this individual eligible concludes. treatment services shall be provided for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
(c)If an individual is diagnosed with a reoccurrence of breast cancer or cervical cancer, whether at the original cancer site or a different cancer site, and meets all other applicable eligibility requirements, the individual shall be eligible for an additional period of treatment coverage, as described in subdivision (a) or (b), respectively. the individual shall be eligible for coverage for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
SEC. 3.Section 104162.1 of the Health and Safety Code is amended to read:104162.1.When If an individual is underinsured, as defined in subdivision (g) (f) of Section 104161, the State Department of Health Care Services shall be the payer of second resort for treatment services. To the extent necessary for the individual to obtain treatment services under any health care insurance listed in paragraph (2), (3), or (4) of subdivision (f) (e) of Section 104161, the State Department of Health Care Services may do the following:
(a)Pay for the individuals breast or cervical cancer copayments, premiums, and deductible.
(b)Provide only treatment services not otherwise covered by any health care insurance listed in paragraph (2), (3), or (4) of subdivision (f) (e) of Section 104161.
|
Date
|
Status
|
|---|---|
| Jun 26, 2018 | June 26 set for first hearing canceled at the request of author. |
| Jun 11, 2018 | Referred to Com. on HEALTH. |
| May 29, 2018 | In Assembly. Read first time. Held at Desk. |
| May 29, 2018 | Read third time. Passed. (Ayes 38. Noes 0.) Ordered to the Assembly. |
| May 25, 2018 | From committee: Do pass. (Ayes 7. Noes 0.) (May 25). |
| May 23, 2018 | Set for hearing May 25. |
| May 22, 2018 | May 22 hearing: Placed on APPR. suspense file. |
| May 14, 2018 | Set for hearing May 22. |
| Apr 26, 2018 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (April 25). Re-referred to Com. on APPR. |
| Mar 12, 2018 | Set for hearing April 25. |
| Feb 8, 2018 | Referred to Com. on HEALTH. |
| Jan 30, 2018 | From printer. May be acted upon on or after March 1. |
| Jan 29, 2018 | Introduced. Read first time. To Com. on RLS. for assignment. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 29, 2018 | Senate 3rd Reading SB945 Atkins et al. | Senate Floor |
Passed |
|
| May 25, 2018 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| May 22, 2018 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 25, 2018 | Do pass, but first be re-referred to the Committee on [Appropriations] | Senate Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 945 |
THIRD READING
Bill No: SB 945
Introduced: 1/29/18
SENATE HEALTH COMMITTEE: 9-0, 4/25/18
AYES: Hernandez, Nguyen, Leyva, Mitchell, Monning, Newman, Nielsen, Pan, Roth
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/25/18
AYES: Lara, Bates, Beall, Bradford, Hill, Nielsen, Wiener
SUBJECT: Breast and Cervical Cancer Treatment Program
SOURCE: California Affiliates of Susan G. Komen
DIGEST:
- This bill deletes time limits for breast and cervical cancer treatment under the state’s Breast and Cervical Cancer Treatment Program, as specified, and instead requires treatment services to continue for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
Existing law:
- Requires the Department of Health Care Services (DHCS) to develop and maintain the Breast and Cervical Cancer Treatment Program (BCCTP) to provide coverage for breast and cervical cancer treatment and services related to a cancer diagnosis. [HSC §104160]
- Limits the treatment coverage for initial diagnosis or reoccurrence of breast cancer to a period not to exceed 18 months, and for initial diagnosis or reoccurrence of cervical cancer not to exceed 24 months. Deems an individual’s eligibility as having concluded after the respective limits for each cancer condition have been reached. [HSC §104161.1]
This bill deletes the time limits for breast and cervical cancer treatment, as specified in 2) of existing law above, and instead requires treatment services to continue for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
Background
According to the American Cancer Society (ACS)’s Cancer Facts & Figures 2017, breast cancer incidence in California has been fairly stable since 1988, are being diagnosed at an early stage. There were 25,801 new cases of breast cancer diagnosed in 2014 (the most recent year for which data is available). A total of 4,460 breast cancer deaths occurred in California in 2014. Breast cancer mortality in the state has declined by 37% due to the combined effects of better treatment and earlier diagnosis. Roughly 170 men are diagnosed with breast cancer each year in California, and about 40 die of the disease annually. The ACS report states that there were a total of 1,391 new cases of cervical cancer diagnosed in California in 2014, with a total of 472 associated deaths. ACS states that mortality rates have declined rapidly in the past decades due to prevention and early detection as a result of Pap test screening, but that those rates have begun to level off in recent years. According to the National Cancer Institute (2015), the average cost of care for breast cancer in women 65 or older is $23,078 for initial treatment (the first year of treatment) and $2,207 for continuing treatment (almost half (42.8%) of all breast cancer diagnoses are in women age 65 or older).
California screening and treatment pipeline for underinsured. The Every Woman Counts (EWC) provides free clinical breast exams, mammograms, pelvic exams, and Pap tests to California's low income uninsured and underserved women. These screening services facilitate early detection that may prevent untimely cancer deaths. In fiscal year 2015-16, EWC provided screening and diagnostic services to nearly 162,378 women. Family PACT provides comprehensive family planning services to nearly 1.1 million women and men, including all FDA-approved forms of contraception, emergency contraception, pregnancy testing with counseling, preconception counseling, male and female sterilization, limited infertility services, STI [sexually transmitted infection] testing and treatment, cancer screening, and HIV screening.
BCCTP provides cancer treatment and services for eligible low-income California residents who are screened by the EWC or Family PACT programs and diagnosed with breast and/or cervical cancer. An individual may receive coverage through BCCTP if he/she has been diagnosed with breast and/or cervical cancer or needs follow-up care for cancer or precancerous cervical lesions/conditions; is under age 65 who has satisfactory immigration status or is a citizen or national of the United States; is a California resident; has a monthly gross family income at the time of screening and diagnosis at or below 200% of the federal poverty level; and, has no other health insurance. BCCTP provides treatment coverage for approximately 9,000 individuals each year, through both federal and state funding.
Currently, the state-funded BCCTP is not aligned with the federally funded BCCTP, causing gaps in service and treatment for women diagnosed and treated through the state-funded program. Under California’s BCCTP, treatment coverage is limited to 18 months for breast cancer and 24 months for cervical cancer. The federal program provides coverage for the duration of treatment.
Author’s statement. According to the author, it is estimated that approximately one in every eight women will have breast cancer during their lifetime. Under the federal Breast and Cervical Cancer Prevention and Treatment Act of 2000, states are authorized to provide women diagnosed with breast or cervical cancer comprehensive health care coverage through Medicaid until the end of their treatment, with no limits on the length of time a state will receive federal reimbursement for it. However, California law limits our state’s BCCTP coverage to 18 months for breast cancer and 24 months for cervical cancer, regardless of medical need. This policy does not align with the values that California stands for. Treatment time can vary dramatically from patient to patient and there is no good reason to stop providing care while someone is still in need of it. SB 945 repeals the arbitrary 18 and 24 month treatment caps of the California BCCTP. In doing so, this bill ensures that the low-income, underinsured, or uninsured women who suffer from breast or cervical cancer that the California BCCTP serves receive proper treatment for as long as they need.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee, DHCS estimates the following fiscal costs:
Fiscal Year | GF Costs |
FY 2018-19 | $8,431,000 |
FY 2019-20 | $10,547,000 |
FY 2020-21 | $8,529,000 |
FY 2021-22 | $7,618,000 |
FY 2022-23 and on-going | $6,880,000 |
California Affiliates of Susan G. Komen (source)
AltaMed Health Services Corporation
American Cancer Society Cancer Action Network
American College of Obstetricians and Gynecologists District IX
Association of California Healthcare Districts
Borrego Community Health Foundation, Inc
Breast Cancer Prevention Partners
California Academy of Family Physicians
California Latinas for Reproductive Justice
California Medical Association
California Women's Law Center
CaliforniaHealth+ Advocates
Cambodian Family Community Center
County Health Executives Association of California
Essential Access Health
Feminist Majority
Health Access California
Legislative Women’s Caucus
Local Health Plans of California
National Association of Social Workers - California Chapter
National Health Law Program
Orange County Herald Center
Pacific Islander Health Partnership
Planned Parenthood of Orange and San Bernardino Counties
Riverside University Health System
Serve the People Community Health Center
Western Center on Law and Poverty
YMCA of North Orange County
OPPOSITION: (Verified 5/23/18)
None received
ARGUMENTS IN SUPPORT: The California Affiliates of Susan G. Komen, the sponsor of this bill, write that it is estimated that approximately one in every eight women will have breast cancer during their lifetime, and this bill will allow women to receive the necessary treatment that they need without having to worry about “how many months are remaining” for their treatment. Health Access California writes that BCCTP’s treatment caps leave patients enrolled in this program with less protection for their cancer coverage than what is required of private insurers because health plans are prohibited from imposing time limits on their enrollees, and this bill will help ensure that people receive the care they need without having to worry about their care ending because of a coverage gap. American Cancer Society Cancer Action Network writes that by removing state-imposed timelines for treatment, this bill will provide uninsured women with the critical coverage they need for as long as they need it. The Association of California Healthcare Districts states that this bill will ensure individuals receive treatment services for the full duration of their illness, which in turn should assist in reducing the mortality rate for low-income women diagnoses with breast and/or cervical cancer. A number of supporters write that this bill will ensure the BCCTP works at its full potential and promotes overall health outcomes of California women by repealing its arbitrary caps on treatment, and in doing so, will help ensure that low-income women in California who are uninsured or underinsured receive the treatment they need, without having to fear that it will be cut short.
5/26/18 15:20:26
**** END ****
SENATE COMMITTEE ON
Senator Ricardo Lara, Chair
2017 - 2018 Regular Session
SB 945 (Atkins) - Breast and Cervical Cancer Treatment Program
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
This bill meets the criteria for referral to the Suspense File.
Bill Summary:
Senate Bill 945 (Atkins) eliminates the 18-month time and 24-month limit for an individual’s eligibility for treatment services due to a diagnosis of breast cancer or of cervical cancer; and requires treatment services to continue for the duration of the treatment period, as long as the individual meets all other eligibility requirements.
Fiscal Impact:
The Department of Health Care Services (DHCS) estimates the following fiscal costs, with additional notes about the assumptions in the staff comments, below.
Fiscal Year | GF Costs |
FY 2018-19 | $8,431,000 |
FY 2019-20 | $10,547,000 |
FY 2020-21 | $8,529,000 |
FY 2021-22 | $7,618,000 |
FY 2022-23 and on-going | $6,880,000 |
Background:
- The DHCS’ Breast and Cervical Cancer Treatment Program (BCCTP) provides cancer treatment and services for eligible low-income California residents who are screened by the Cancer Detection Program: Every Woman Counts (EWC) or Family Planning, Access, Care, and Treatment (PACT) programs and are found to be in need of treatment for breast and/or cervical cancer. BCCTP provides coverage for breast and cervical cancer treatment and services related to your cancer diagnosis. If approved for federal BCCTP, you may receive full scope Medi-Cal coverage which is not limited to breast and cervical cancer treatment and services.
- State-funded BCCTP provides no-cost services limited to breast and/or cervical cancer treatment, related services, and reimbursement of insurance premiums under certain circumstances.
- Prosthetic bras are covered if a prescription is written by a doctor and taken to a Durable Medical Equipment (DME) supply facility that accepts Medi-Cal.
An individual is eligible to receive coverage through BCCTP if they have been screened and found to be in need of treatment for breast and/or cervical cancer or for follow-up care for cancer or precancerous cervical lesions/conditions by an EWC or Family PACT provider; are under age 65 who has satisfactory immigration status or is a citizen or national of the United States; are a California resident; have a monthly gross family income at the time of screening and diagnosis at or below 200% of the federal poverty level; and, have no other health insurance, including full-scope no share-of-cost Medi-Cal or Medicare.
In addition, if an individual is not eligible for full-scope full-scope Medi-Cal coverage under federal BCCTP, an individual may still be eligible for State-funded BCCTP limited or restricted scope Medi-Cal coverage if the following requirements are met:
- Have been screened and found in need of treatment for breast (men and women) and/or cervical cancer (women only), follow-up care for cancer or precancerous cervical lesions/conditions by an EWC or Family PACT provider
- California resident
- Have monthly gross family income at the time of screening and diagnosis, which is at or below 200 percent of the federal poverty level for the family size
- Male of any age or any immigration status
- Female under 65 years of age with unsatisfactory immigration status
- Female 65 years of age or older; and/or
- Have health insurance, including share-of-cost Medi-Cal and/or Medicare
BCCTP provides treatment coverage for approximately 9,000 individuals each year, through both federal and state funding.
Currently, the state-funded BCCTP is not aligned with the federally funded BCCTP, causing gaps in service and treatment for women diagnosed and treated through the state-funded program. Under California’s BCCTP, treatment coverage is limited to 18 months for breast cancer and 24 months for cervical cancer. The federal program provides coverage for the duration of treatment.
Proposed Law:
The bill provides that if an individual is made eligible for treatment services due to a diagnosis of breast cancer or of cervical cancer, the treatment services must be provided for the duration of the treatment period, as long as the individual continues to meet all other eligibility requirements.
The bill provides if an individual is underinsured, as defined in state law, the Department of Health Care Services must be the payer of second resort for treatment services.
Related Legislation:
AB 1795 (Atkins, Chapter 608, Statutes of 2016) requires a patient be eligible for an additional period of treatment coverage if diagnosed with a reoccurrence of breast cancer (for 18 months) or cervical cancer (for 24 months). Requires individuals to be eligible for breast cancer screening and diagnostic services through EWC if they meet eligibility requirements and: a) are of any age and “symptomatic,” as defined; and, b) are within the age range for routine breast cancer screening, as specified.
Staff Comments:
The department made the following assumptions in its estimate of the bill:
• 45% of Group 1 (beneficiaries who are in Year 2 of treatment and need additional treatment) of 975 people.
• 100% of Group 2 (beneficiaries who have already exceeded the cap and come back into the program, will need additional services due to OV aid code, 338 people)
• An average of 777 eligible per month that would exceed cap and need additional services
• Weighted average cost of per month treatment at $904.27
-- END --
SENATE COMMITTEE ON HEALTH
Senator Ed Hernandez, O.D., Chair
BILL NO: SB 945
AUTHOR: | Atkins | ||
VERSION: | January 29, 2018 | ||
HEARING DATE: | April 25, 2018 | ||
CONSULTANT: | Melanie Moreno | ||
SUBJECT: Breast and Cervical Cancer Treatment Program
SUMMARY:
- Deletes time limits for breast and cervical cancer treatment under the state’s Breast and Cervical Cancer Treatment Program, as specified, and instead requires treatment services to continue for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
Existing law:
- Requires the Department of Health Care Services (DHCS) to develop and maintain the Breast and Cervical Cancer Treatment Program (BCCTP) to provide coverage for breast and cervical cancer treatment and services related to a cancer diagnosis. [HSC §104160]
- Limits the treatment coverage for initial diagnosis or reoccurrence of breast cancer to a period not to exceed 18 months, and for initial diagnosis or reoccurrence of cervical cancer not to exceed 24 months. Deems an individual’s eligibility as having concluded after the respective limits for each cancer condition have been reached. [HSC §104161.1]
This bill: Deletes the time limits for breast and cervical cancer treatment, as specified in 2) of existing law above, and instead requires treatment services to continue for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.
FISCAL EFFECT:
This bill has not been analyzed by a fiscal committee.
COMMENTS:
- Author’s statement. According to the author, it is estimated that approximately one in every eight women will have breast cancer during their lifetime. Under the federal Breast and Cervical Cancer Prevention and Treatment Act of 2000, states are authorized to provide women diagnosed with breast or cervical cancer comprehensive health care coverage through Medicaid until the end of their treatment, with no limits on the length of time a state will receive federal reimbursement for it. However, California law limits our state’s BCCTP coverage to 18 months for breast cancer and 24 months for cervical cancer, regardless of medical need. This policy does not align with the values that California stands for. Treatment time can vary dramatically from patient to patient and there is no good reason to stop providing care while someone is still in need of it. SB 945 would repeal the arbitrary 18 and 24 month treatment caps of the California BCCTP. In doing so, this bill would ensure that the low-income, underinsured, or uninsured women who suffer from breast or cervical cancer that the California BCCTP serves receive proper treatment for as long as they need.
- Background. According to the American Cancer Society (ACS)’s Cancer Facts & Figures 2017, breast cancer incidence in California has been fairly stable since 1988, are being diagnosed at an early stage. There were 25,801 new cases of breast cancer diagnosed in 2014 (the most recent year for which data is available). A total of 4,460 breast cancer deaths occurred in California in 2014. Breast cancer mortality in the state has declined by 37% due to the combined effects of better treatment and earlier diagnosis. Roughly 170 men are diagnosed with breast cancer each year in California, and about 40 die of the disease annually. The ACS report states that there were a total of 1,391 new cases of cervical cancer diagnosed in California in 2014, with a total of 472 associated deaths. ACS states that mortality rates have declined rapidly in the past decades due to prevention and early detection as a result of Pap test screening, but that those rates have begun to level off in recent years. According to the National Cancer Institute (2015), the average cost of care for breast cancer in women 65 or older is $23,078 for initial treatment (the first year of treatment) and $2,207 for continuing treatment (almost half (42.8%) of all breast cancer diagnoses are in women age 65 or older).
- California screening and treatment pipeline for underinsured. The Every Woman Counts (EWC) provides free clinical breast exams, mammograms, pelvic exams, and Pap tests to California's low income uninsured and underserved women. These screening services facilitate early detection that may prevent untimely cancer deaths. In fiscal year 2015-16, EWC provided screening and diagnostic services to nearly 162,378 women. Family PACT provides comprehensive family planning services to nearly 1.1 million women and men, including all FDA- approved forms of contraception, emergency contraception, pregnancy testing with counseling, preconception counseling, male and female sterilization, limited infertility services, STI testing and treatment, cancer screening, and HIV screening.
BCCTP provides cancer treatment and services for eligible low-income California residents who are screened by the EWC or Family PACT programs and found to be in need of treatment for breast and/or cervical cancer. An individual may receive coverage through BCCTP if he/she has been screened and found to be in need of treatment for breast (women and men) and/or cervical cancer or for follow-up care for cancer or precancerous cervical lesions/conditions by an EWC or Family PACT provider; is under age 65 who has satisfactory immigration status or is a citizen or national of the United States; is a California resident; has a monthly gross family income at the time of screening and diagnosis at or below 200% of the federal poverty level; and, has no other health insurance. BCCTP provides treatment coverage for approximately 9,000 individuals each year, through both federal and state funding.
Currently, the state-funded BCCTP is not aligned with the federally funded BCCTP, causing gaps in service and treatment for women diagnosed and treated through the state-funded program. Under California’s BCCTP, treatment coverage is limited to 18 months for breast cancer and 24 months for cervical cancer. The federal program provides coverage for the duration of treatment.
- Prior legislation. AB 1795 (Atkins, Chapter 608, Statutes of 2016) requires a patient be eligible for an additional period of treatment coverage if diagnosed with a reoccurrence of breast cancer (for 18 months) or cervical cancer (for 24 months). Requires individuals to be eligible for breast cancer screening and diagnostic services through EWC if they meet eligibility requirements and: a) are of any age and “symptomatic,” as defined; and, b) are within the age range for routine breast cancer screening, as specified.
AB 49 (Buchanan, Chapter 351, Statutes of 2014) established the breast cancer awareness special interest license plate program to generate funds to raise awareness of early breast cancer screening. Requires the proceeds from the license plate sales to be deposited in the Breast Cancer Control Account to fund EWC programming.
SB 1348 (Cedillo of 2008) would have required the Department of Public Health to provide breast cancer screening services to women who are 38 years of age and older and who meet other eligibility standards for breast cancer screening services under existing state and federal law. SB 1248 was held under submission in the Senate Appropriations Committee.
AB 478 (Friedman, Chapter 660, Statutes of 1993) established a $.02 tax on each pack of cigarettes sold, with the revenue deposited in the BCF and the proceeds to be divided equally between the Breast Cancer Research Account and the Breast Cancer Control Account.
AB 2055 (Freidman, Chapter 661, Statutes of 1993) established the Breast Cancer Control Account for purposes of breast cancer research, detection services, and education. Modified the allocation of tobacco tax funds so that 50% of the funds are devoted to research and 50% for early detection services for uninsured and underinsured women.
- Support. The California Affiliates of Susan G. Komen, the sponsor of this bill, write that it is estimated that approximately one in every eight women will have breast cancer during their lifetime, and this bill will allow women to receive the necessary treatment that they need without having to worry about “how many months are remaining” for their treatment. Health Access California writes that BCCTP’s treatment caps leave patients enrolled in this program with less protection for their cancer coverage than what is required of private insurers because health plans are prohibited from imposing time limits on their enrollees, and this bill will help ensure that people receive the care they need without having to worry about their care ending because of a coverage gap. ACS Cancer Action Network writes that by removing state-imposed timelines for treatment, this bill will provide uninsured women with the critical coverage they need for as long as they need it. The Association of California Healthcare Districts states that this bill will ensure individuals receive treatment services for the full duration of their illness, which in turn should assist in reducing the mortality rate for low-income women diagnoses with breast and/or cervical cancer. A number of supporters write that this bill will ensure the BCCTP works at its full potential and promotes overall health outcomes of California women by repealing its arbitrary caps on treatment, and in doing so, will help ensure that low-income women in California who are uninsured or underinsured receive the treatment they need, without having to fear that it will be cut short.
SUPPORT AND OPPOSITION:
Support: California Affiliates of Susan G. Komen (sponsor)
AltaMed Health Services Corporation
Association of California Healthcare Districts
American Cancer Society Cancer Action Network
American College of Obstetricians and Gynecologists District IX
Borrego Community Health Foundation, Inc
Breast Cancer Prevention Partners
California Academy of Family Physicians
CaliforniaHealth+ Advocates
California Latinas for Reproductive Justice
California Medical Association
California Women's Law Center
Cambodian Family Community Center
County Health Executives Association of California
Essential Access Health
Feminist Majority
Health Access California
National Association of Social Workers - California Chapter
National Health Law Program
Orange County Herald Center
Pacific Islander Health Partnership
Planned Parenthood of Orange and San Bernardino Counties
Riverside University Health System
Serve the People Community Health Center
Western Center on Law and Poverty
YMCA of North Orange County
Oppose: None received
-- END --
Discussed in Hearing
View Older HearingsBill Author
Bill Co-Author(s):